Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Test How Much BI 3034701 Gets Into the Blood in Healthy People When Given in Two Different Ways
Sponsor: Boehringer Ingelheim
Summary
The aim of the trial is to investigate relative bioavailability of BI 3034701 treatment T vs. BI 3034701 treatment R.
Official title: Relative Bioavailability of Two Different BI 3034701 Treatments Following Subcutaneous Administration in Healthy Male and Female Participants (an Open-label, Randomised, Single-dose, Two-period, Two-sequence, Crossover Trial)
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-10-05
Completion Date
2026-12-24
Last Updated
2026-10-19
Healthy Volunteers
Yes
Conditions
Interventions
BI3034701 formulation II
BI3034701 formulation II (reference treatment)
BI3034701 formulation C1
BI3034701 formulation C1 (test treatment)
Locations (1)
Quotient Sciences
Nottingham, United Kingdom